.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Express Scripts
Julphar
UBS
US Department of Justice
Moodys
Covington
Chubb
Accenture
Harvard Business School

Generated: September 24, 2017

DrugPatentWatch Database Preview

COLESTID Drug Profile

« Back to Dashboard

What is the patent landscape for Colestid, and when can generic versions of Colestid launch?

Colestid is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in COLESTID is colestipol hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

Summary for Tradename: COLESTID

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list5
Bulk Api Vendors: see list5
Clinical Trials: see list1
Patent Applications: see list20
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COLESTID at DailyMed

Pharmacology for Tradename: COLESTID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
COLESTID
colestipol hydrochloride
TABLET;ORAL020222-001Jul 19, 1994ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
COLESTID
colestipol hydrochloride
GRANULE;ORAL017563-003Sep 22, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
COLESTID
colestipol hydrochloride
GRANULE;ORAL017563-004Sep 22, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: COLESTID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
COLESTID
colestipol hydrochloride
TABLET;ORAL020222-001Jul 19, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for COLESTID

Drugname Dosage Strength RLD Submissiondate
colestipol hydrochlorideTablets1 gColestid8/23/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Express Scripts
McKinsey
Citi
QuintilesIMS
UBS
Cipla
Cantor Fitzgerald
Deloitte
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot